Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

This bill requires New Jersey's Department of Health to create a program that buys and distributes xylazine test strips to organizations authorized to provide harm reduction services. The Department will manage bulk purchases, distribute the strips upon request from these organizations, and maintain a website to inform the public about xylazine and where to access the test strips. The program will be funded through available federal funds and state appropriations from the General Fund. This legislation takes effect immediately upon passage.